ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "bone metabolism"

  • Abstract Number: 1967 • 2012 ACR/ARHP Annual Meeting

    Hypophosphatemic Osteomalacia Induced by Tenofovir in Patients with Human Immunodeficiency Virus Infection

    Beatriz Tejera1, Lourdes Mateo-Soria2, Susana Holgado3, Luisa Mariñoso4, Ricard Pérez5, Anna Bonjoch6, Melania Martínez-Morillo7, Dolors Grados3 and Alejandro Olivé3, 1Rheumatology, University Hospital of Canary Islands, Santa Cruz de Tenerife, Spain, 2Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 3Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 4Pathology, Hospital del Mar, Barcelona, Spain, 5Radiology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 6HIV Unit, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 7Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain

    Background/Purpose: treatment of human immunodeficiency virus (HIV) infection has dramatically changed survival prognosis of these patients.New drugs included in antiretroviral therapy are much more effective. …
  • Abstract Number: 1973 • 2012 ACR/ARHP Annual Meeting

    Effect of Adalimumab On the Serum Level of Undercarboxylated Osteocalcin (ucOC), Bone Biochemical Markers and Bone Mineral Density

    Yoshitada Sakai1, Akira Hashiramoto2, Takaichi Okano2, Yoshiko Kawasaki3, Nao Shibanuma4 and Masahiro Kurosaka5, 1The Center of Rheumatic Diseases/ Division of Rehabilitation Medicine, Kobe University Hospital, Kobe, Japan, 2The Center for Rheumatic Diseases,, Kobe University Hospital, Kobe, Japan, 3The Center of Rheumatic Diseases, Kobe University Hospital, Kobe, Japan, 4The Center for Rheumatic Diseases, Kobe University Hospital / Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 5Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan

    Background/Purpose: The osteoporotic fracture in patients with rheumatiod arthritis (RA) is caused by systemic osteoporosis as well as periarticular osteoporosis, On the other hand, the…
  • Abstract Number: 1789 • 2012 ACR/ARHP Annual Meeting

    Evidence for an Additive Effect of Tumor Necrosis Factor Alpha and Hypoxia to Promote Bone Destruction in Arthritis

    Shankar Revu1, Akilan Krishnamurthy2, Vivekananda Sunkari3, Ileana R. Botusan3, Xiaowei Zheng3, Sergiu-Bogdan Catrina4 and Anca Catrina1, 1Department of Medicine, Rheumatology unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 2Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 4Molecular Medicine and Surgery, Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Hypoxia is a major feature of the inflamed rheumatoid arthritis synovial membrane and promotes osteoclasts formation in vitro. We aimed to investigate the molecular…
  • Abstract Number: 1281 • 2012 ACR/ARHP Annual Meeting

    IL-6 Signaling Inhibition Improves Abnormal Bone Homeostasis in Active Rheumatoid Arthritis

    Masayasu Kitano1, Sachie Kitano1, Chieri Sato1, Kazuyuki Fujita1, Takahiro Yoshikawa1, Yuki Katashima1, Masahiro Sekiguchi1, Naoto Azuma1, Naoaki Hashimoto, Shinichiro Tsunoda1, Kiyoshi Matsui1 and Hajime Sano1, 1Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya-city, Japan

    Background/Purpose: Tocilizumab (TCZ) is a humanized monoclonal anti-IL-6 receptor antibody. TCZ has demonstrated efficacy in moderate to severe active rheumatoid arthritis (RA) with inadequate clinical…
  • Abstract Number: 1209 • 2012 ACR/ARHP Annual Meeting

    Functional Role of Chondrogenic Progenitor Cells in Rheumatoid Arthritis

    Sabine Blaschke1, Sandra Trautmann1, Alexander W. Beham2, Burkhard Mai3, Sebastian Koelling1, Caroline Breysach4, Gabriele Wolf1, Gerhard A. Mueller1 and Nicolai Miosge5, 1Nephrology & Rheumatology, University Medical Center Goettingen, Goettingen, Germany, 2Department of Surgery, Germany, 3Vitos Orthopaedic Clinic Kassel, Kassel, Germany, 4Department of Surgery, Goettingen, Germany, 5Dept. of Prosthodontics, Goettingen, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease of still unknown etiology leading to progressive cartilage and bone destruction. Proinflammatory cytokines, immunoregulatory cells…
  • Abstract Number: 1007 • 2012 ACR/ARHP Annual Meeting

    High Resolution Peripheral Quantitative CT Detects Marked Differences in Metacarpal Head and Shaft and Ultra-Ultra-Distal Radius Bone Volumetric Density and Microstructure in Early Rheumatoid Arthritis

    Lynne M. Feehan1, Helen R. Buie2, Linda C. Li1, Kamran Shojania3, Cheryl Barnabe4 and Heather A. McKay5, 1Physical Therapy, Arthritis Research Centre of Canada and University of British Columbia, Vancouver, BC, Canada, 2Mechanical Engineering, University of Calgary, Calgary, AB, Canada, 3Rheumatology, University of British Columbia, Vancouver, BC, Canada, 4Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, 5Family Practice and Orthoepedics, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose:  Despite improvements in clinical management of rheumatoid arthritis (RA), many with early disease are still at high risk for developing periarticular erosions and osteopenia,…
  • Abstract Number: 823 • 2012 ACR/ARHP Annual Meeting

    Positive Effects of Tocilizumab On Bone Remodeling in Patients with Rheumatoid Arthritis

    Karine Briot1, Thierry Schaeverbeke2, Fabien Etchepare3, Philippe Gaudin4, Aleth Perdriger5, Muriel Vray6, Stephanie Rouanet7, Ghislaine Steinberg8 and Christian Roux1, 1Cochin hospital, Paris Descartes University, Paris, France, 2Service de Rhumatologie, Groupe Hospitalier Pellegrin, Bordeaux, France, 3G.H. Pitié-Salpêtrière, Paris, France, 4Rheumatology Department, CHU Hôpital Sud, Grenoble Teaching Hospital, Echirolles, France, 5Rheumatology, Hôpital Sud, Rennes, France, 6Institut Pasteur, Paris, France, 7Medical Department, Roche, Boulogne-Billancourt, France, 8Medical Department, Roche, Neuilly sur Seine, France

    Background/Purpose: The anti-IL6-R antibody tocilizumab (TCZ) is an effective treatment of rheumatoid arthritis (RA). Previous studies showed that TCZ has a positive effect on bone…
  • Abstract Number: 594 • 2012 ACR/ARHP Annual Meeting

    Evidence of Human Leucozyte Antigen-B27 in Healthy Individuals and Patients with Uveitis Is a Risk Factor for Alterations in Bone Metabolism

    Sarah Schmidt1, Stephanie Finzel1, Jürgen Rech2, Matthias Englbrecht1, Silke Winkler1, Isabel Schmidt1, Roula Said-Nahal3, Maxime A. Breban3 and Georg A. Schett1, 1Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Medizinische Klinik 3, University of Erlangen-Nuremberg, Erlangen, Germany, 3Rheumatology Division, Ambroise Paré Hospital (AP-HP), and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France

    Background/Purpose: To test whether positivity for HLA-B27 per se is associated with changes of biomarkers of the Wnt pathway. HLA-B27 is strongly associated with the…
  • Abstract Number: 35 • 2012 ACR/ARHP Annual Meeting

    Changes in Tibial Bone and Cartilage Structure in a Mouse Surgical Model of Osteoarthritis

    Brett A. Tonkin1, Evange Romas2, Natalie A. Sims1 and Nicole C. Walsh1, 1St Vincent's Institute of Medical Research, Melbourne, Australia, 2Dept. of Rheumatology, St Vincent's Hospital, Melbourne, Australia

    Background/Purpose: The destabilisation of the medial meniscus (DMM) mouse osteoarthritis (OA) model is commonly used to study OA joint degeneration. In DMM-OA, the knee is…
  • Abstract Number: 38 • 2012 ACR/ARHP Annual Meeting

    Bone Marrow Lesions On Magnetic Resonance Imaging Are Not Associated with Regions of Hypermetabolism in an Animal Model of Osteoarthritis

    Arash Panahifar1, Jacob Jaremko2, Robert GW Lambert2, Walter P. Maksymowych3 and Michael R. Doschak1, 1Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada, 2Radiology, University of Alberta, Edmonton, AB, Canada, 3Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: The underlying histopathological basis for bone marrow lesions (BML) on magnetic resonance imaging (MRI) in osteoarthritis (OA) is unclear, but may be associated with…
  • Abstract Number: 44 • 2012 ACR/ARHP Annual Meeting

    Inhibition of WNT Signaling Pathway by Sclerostin Maintains Cartilage Homeostasis

    Wafa Bouaziz1, Thomas Funck-Brentano1, Hilene Lin1, Eric Hay1 and Martine Cohen-Solal2, 1INSERM U606 Paris 7 university, Paris, France, 2Rhumatologie A, INSERM U606 Hôpital Lariboisière, Centre Viggo Petersen, Paris, France

    Background/Purpose: Cartilage homeostasis is regulated by several mechanisms that influence the anabolic and catabolic tissue balance. Among them, the local activation of Wnt signaling pathway…
  • Abstract Number: 16 • 2012 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor Diminishes Bone Destruction At Inflamed Sites, in Part, Via Downregulating Semaphorin4D-PlexinB1 Communication Between Osteoclasts and Osteoblasts

    Aranzazu Mediero1 and Bruce N. Cronstein2, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Communication between osteoclasts and osteoblasts is essential for bone homeostasis. Semaphorin4D (Sema4D), expressed on the surface of and secreted by osteoclasts, macrophages and T…
  • Abstract Number: 24 • 2012 ACR/ARHP Annual Meeting

    The Negative Effects of Glucocorticoids On Bone Are Primarily Mediated by Genes Involved in Osteoblast Differentiation and Bone Remodelling

    Katharina Blankenstein1, Tara C. Brennan-Speranza1, Karin Lyon1, Colin R. Dunstan1, Frank Buttgereit2, Hong Zhou3 and Markus J. Seibel3, 1ANZAC Research Institute, Concord, NSW, Bone Research Program, Sydney, Australia, 2Charité - Universitätsmedizin Berlin, Berlin, Germany, 3Bone Research Program, ANZAC Research Institute, The University of Sydney, Concord, Australia

    Background/Purpose: Glucocorticoids are widely used as anti-inflammatory and immunosuppressive drug for the treatment of many inflammatory and auto-immune diseases. However, long-term and high-dose glucocorticoid treatment…
  • Abstract Number: 25 • 2012 ACR/ARHP Annual Meeting

    Activation of the Canonical Wnt Signaling Pathway Is Tissue Dependent in Osteoarthritic Joints: Distinct Mechanisms of Regulation by Wnt Antagonists

    Thomas Funck-Brentano1, Wafa Bouaziz1, Hilene Lin1, Valerie Geoffroy1, Eric Hay1 and Martine Cohen-Solal2, 1INSERM U606 Paris 7 university, Paris, France, 2Rhumatologie A, INSERM U606 Hôpital Lariboisière, Centre Viggo Petersen, Paris, France

    Background/Purpose: Wnt signaling pathway is a major regulator of bone and cartilage remodeling. Modulation of this pathway has lead to controversial results on joint cartilage…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology